收藏切换
Cost-effectiveness analysis of three therapeutic schemes in the treatment of child acute upper respiratory infection
收藏切换
Hui-min PENG1, Jian-mei CHEN2, Shuai MA1
World Clinical Drug | 2018, 39(10) : 691 - 694
Less
收藏切换
World Clinical Drug | 2018, 39(10): 691-694
• Article •
Cost-effectiveness analysis of three therapeutic schemes in the treatment of child acute upper respiratory infection
Full
Hui-min PENG1, Jian-mei CHEN2, Shuai MA1
Affiliations
  • 1.Department of Pediatrics, Urumqi First People's Hospital, Urumqi 830011
  • 2.Department of Rheumatology, Urumqi Children's Hospital, Urumqi 830011, China
Published: 2018-10-10 doi: 10.13683/j.wph.2018.10.009
Outline
收藏切换
Objective

To analyze the cost-effectiveness of three therapeutic regimens in the treatment of child acute upper respiratory infection (AURI).

Methods

A total of 92 children with AURI admitted in our hospital from April 2015 to July 2016 were enrolled and divided to three groups. The group A (n=30) was treated with cefotiam for injection, the group B (n=34) was treated with cefaclor plus bromhexine hydrochloride suspension and the group C (n=28) was treated with Yanhuning injection combined with Qingkailing injection. The treatment was lasted about 7 days. The efficacy, adverse drug reactions and drug economic costs of the three groups were compared.

Results

Compared with the group B and group C, the group A had a lower number of cured cases, more invalid cases and a longer hospital stay (P<0.05), but the total effective rate of the three groups was similar. The drug cost-effectiveness ratio of group C was the highest, while that in group B was the lowest. No obvious adverse drug reactions were observed in all groups.

Conclusion

Compared with cefotiam and the Yanhuning injection combined with Qingkailing injection, the cefaclor plus bromhexine hydrochloride suspension has lower cost and similar efficacy in the treatment of child AURI.

acute upper respiratory infection  /  child  /  pharmacoeconomics  /  therapeutic scheme
彭慧敏, 陈建梅, 马帅. 三种治疗方案用于儿童急性上呼吸道感染治疗的药物经济学分析. 世界临床药物, 2018 , 39 (10) : 691 -694 . DOI: 10.13683/j.wph.2018.10.009
Hui-min PENG, Jian-mei CHEN, Shuai MA. Cost-effectiveness analysis of three therapeutic schemes in the treatment of child acute upper respiratory infection[J]. World Clinical Drug, 2018 , 39 (10) : 691 -694 . DOI: 10.13683/j.wph.2018.10.009
Year 2018 volume 39 Issue 10
19
6
Cite this Article
BibTeX
Article Info
doi: 10.13683/j.wph.2018.10.009
  • Receive Date:2018-04-21
  • Online Date:2026-11-18
  • Published:2018-10-10
Article Data
Affiliations
History
  • Received:2018-04-21
  • Revised:2018-08-21
Affiliations
    1.Department of Pediatrics, Urumqi First People's Hospital, Urumqi 830011
    2.Department of Rheumatology, Urumqi Children's Hospital, Urumqi 830011, China
References
Share
https://castjournals.cast.org.cn/joweb/sjlcyw/EN/10.13683/j.wph.2018.10.009
Share to
QR

Scan QR to access full text

Cite this article
BibTeX
Citations
表12种不同金属材料的力学参数
科
Family
属数
Number of
genus
种数
Number of
species
占总种数比例
Percentage of
total species (%)
属
Genus
种数
Number of
species
占总种数比例
Percentage of total
species (%)
鹅膏菌科Amanitaceae 2 11 5.26 鹅膏菌属 Amanita 10 4.78
小菇科 Mycenaceae 2 12 5.74 丝盖伞属 Inocybe 5 2.39
多孔菌科 Polyporaceae 8 14 6.70 蜡蘑属 Laccaria 5 2.39
红菇科 Russulaceae 3 23 11.00 小皮伞属 Marasmius 6 2.87
小菇属 Mycena 11 5.26
光柄菇属 Pluteus 5 2.39
红菇属 Russula 17 8.13
栓菌属 Trametes 5 2.39
关闭全屏
  • BibTeX
  • EndNote
  • RefWorks
  • TxT